Continuous propofol perfusion in critically ill children;Propofol en perfusión continua en niños en estado crítico

Medicina Intensiva

Volumn 36, Issue 6, 2012, Pages 410-415

  Agudelo, S C ^a   Mencia S ^b   Faro, A ^c   Escudero, V ^b   Sanavia, E ^b   Lopez Herce J ^b  

^a PONTIFICIA UNIVERSIDAD JAVERIANA   (Colombia)

^b HOSPITAL GENERAL UNIVERSITARIO GREGORIO MARAÑÓN   (Spain)

^c HOSPITAL DO DIVINO ESPÍRITO SANTO   (Portugal)

Author keywords

Pediatric intensive care; Propofol; Propofol infusion syndrome; Sedation

Indexed keywords

FENTANYL; LACTIC ACID; MIDAZOLAM; PROPOFOL;

ABNORMAL LABORATORY RESULT; ARTICLE; CHILD; CONTINUOUS INFUSION; CRITICALLY ILL PATIENT; DESCRIPTIVE RESEARCH; DRUG SAFETY; FEMALE; HUMAN; INCIDENCE; INFECTION; INFUSION RELATED REACTION; INTENSIVE CARE UNIT; LACTATE BLOOD LEVEL; MAJOR CLINICAL STUDY; MALE; OBSERVATIONAL STUDY; PEDIATRIC ANESTHESIA; PRESCHOOL CHILD; RETROSPECTIVE STUDY; SEDATION; TREATMENT DURATION;

ANALGESIA, EPIDURAL; ANALGESICS; CHILD; CHILD, PRESCHOOL; CRITICAL CARE; CRITICAL ILLNESS; DIPYRONE; DRUG INTERACTIONS; DRUG THERAPY, COMBINATION; FEMALE; FENTANYL; HUMANS; HYPNOTICS AND SEDATIVES; INFANT; INFUSIONS, INTRAVENOUS; INTENSIVE CARE UNITS, PEDIATRIC; MALE; MIDAZOLAM; PARENTERAL NUTRITION, TOTAL; PIPERIDINES; PROPOFOL; RETROSPECTIVE STUDIES; SPAIN; VASOCONSTRICTOR AGENTS;

EID: 84864304330     PISSN: 02105691     EISSN: 15786749     Source Type: Journal    
DOI: 10.1016/j.medin.2011.11.018     Document Type: Article

References (31)

1. Conti G., Mercurio G., Iacobone E., Auricchio D., Liberati Q. Sedation in the Intensive Care Unit. The basis of the problem. Sedation. Minerva Anestesiol 2002, 68:240-244.
2. Marik P.E. Propofol: therapeutic indications and side-effects. Curr Pharm Des 2004, 10:3639-3649.
3. Hall R.I., Sandham D., Cardinal P., Tweeddale M., Moher D., Wang X., et al. Study Investigators. Propofol vs midazolam for ICU sedation: a Canadian multicenter randomized trial. Chest 2001, 119:1151-1159.
4. Valdivielso A. Dolor agudo, analgesia y sedación en el niño (IIIb): Farmacocinética y farmacodinamia de los sedantes. An Esp Pediatr 1998, 48:541-548.
5. Hertzog J.H., Dalton H.J., Anderson B.D., Shad A.T., Gootenberg J.E., Hauser G.J. Prospective evaluation of propofol anesthesia in the pediatric intensive care unit for elective oncology procedures in ambulatory and hospitalized children. Pediatrics 2000, 106:742-747.
6. Alados-Arboledas F.J., Millán-Bueno P., Expósito-Montes J.F., de la Cruz-Moreno J., Pérez-Parras A., Arévalo-Garrido A. [Safety and efficacy of continuous infusión propofol for diagnostic upper gastrointestinal endoscopy in spontaneous breathing]. An Pediatr (Barc) 2011, 75:124-128.
7. Valdivielso-Serna A. Grupo de Trabajo de Analgesia y Sedación de la SEMICYUC. Analgesia, sedation and relaxation in the child with mechanical ventilation. Med Intensiva 2008, 32:115-124.
8. López J.M., Valerón M., Pérez O., Consuegra E., Urquía L., Morón A., et al. Seguridad y efectividad de la sedoanalgesia con fentanilo y propofol. Experiencia en una unidad de medicina intensiva pediátrica. Med Intensiva 2007, 31:417-422.
9. Bray R.J. The propofol infusion syndrome in infants and children: can we predict the risk. Curr Opin Anaesthesiol 2002, 15:339-342.
10. Cremer O.L., Moons K.G., Bouman E.A., Kruijswijk J.E., de Smet A.M., Kalkman C.J. Long-term propofol infusion and cardiac failure in adult head-injured patients. Lancet 2001, 357:117-118.
11. Cornfield D.N., Tegtmeyer K., Nelson M.D., Milla C.E., Sweeney M. Continuous propofol infusion in 142 critically ill children. Pediatrics 2002, 110:1177-1181.
12. Roberts R.J., Barletta J.F., Fong J.J., Schumaker G., Kuper P.J., Papadopoulos S., et al. Incidence of propofol-related infusion syndrome in critically ill adults: a prospective, multicenter study. Crit Care 2009, 13:R169.
13. Vasile B., Rasulo F., Candiani A., Latronico N. The pathophysiology of propofol infusion syndrome: a simple name for a complex syndrome. Intensive Care Med 2003, 29:1417-1425.
14. Parke T.J., Stevens J.E., Rice A.S., Greenaway C.L., Bray R.J., Smith P.J., et al. Metabolic acidosis and fatal myocardial failure after propofol infusion in children: five case reports. BMJ 1992, 12:613-616.
15. Hartman M.E., McCrory D.C., Schulman S.R. Efficacy of sedation regimens to facilitate mechanical ventilation in the pediatric intensive care unit: a systematic review. Pediatr Crit Care Med 2009, 10:246-255.
16. Goodale D. Letter from AstraZeneca to US Physicians 26th March 2001, AstraZeneca, Wilmigton DE, USA.
17. Propofol (Diprivan) infusion: sedation in children aged 16 years or younger contraindicated. Current Problems in Pharmacovigilance 2001, 27-30. Committee on Safety of Medicines, medicines Control agency.
18. Crawford M.W., Dodgson B.G., Holtby H.H., Roy W.L. Propofol syndrome in children. CMAJ 2003, 168:669.
19. Felmet K., Nguyen T., Clark R.S., Orr D., Carcillo J. The FDA Warning Against Prolonged Sedation With Propofol in Children Remains Warranted. Pediatrics 2003, 112:1002-1003.
20. Wooltorton E. Propofol: contraindicated for sedation of pediatric intensive care patients. CMAJ 2002, 167:507.
21. Tobias J.D. Sedation and analgesia in the pediatric intensive care unit. Pediatr Ann 2005, 34:636-645.
22. Playfor S., Jenkins I., Boyles C., Choonara I., Davies G., Haywood T., et al. Consensus guidelines on sedation and analgesia in critically ill children. Intensive Care Med 2006, 32:1125-1136. United Kingdom Paediatric Intensive Care Society Sedation; Analgesia and Neuromuscular Blockade Working Group.
23. Jenkins I.A., Playfor S.D., Bevan C., Davies G., Wolf A.R. Current United Kingdom sedation practice in pediatric intensive care. Paediatr Anaesth 2007, 17:675-683.
24. Twite M.D., Rashid A., Zuk J., Friesen R.H. Sedation, analgesia, and neuromuscular blockade in the pediatric intensive care unit: survey of fellowship training programs. Pediatr Crit Care Med 2004, 5:521-532.
25. Benini F., Farina M., Capretta A., Messeri A., Cogo P. Sedoanalgesia in paediatric intensive care: a survey of 19 Italian units. Acta Paediatr 2010, 99:758-762.
26. Festa M., Bowra J., Schell D. Use of propofol infusion in Australian and New Zealand paediatric intensive care units. Anaesth Intensive Care 2002, 30:786-793.
27. Mencía S., Botrán M., López-Herce J., del Castillo J. Grupo de Estudio de Sedoanalgesia de la SECIP. Manejo de la sedoanalgesia y de los relajantes musculares en las unidades de cuidados intensivos pediátricos españolas. An Pediatric (Barc) 2011, 74:396-404.
28. Zaccheo M.M., Bucher D.H. Propofol Infusion Syndrome: A Rare Complication With Potentially Fatal. Crit Care Nurse 2008, 28:18-26.
29. Teng S.N., Kaufman J., Czaja A.S., Friesen R.H., da Cruz E.M. Propofol as a bridge to extubation for high-risk children with congenital cardiac disease. Cardiol Young 2011, 21:46-51.
30. Xia W.F., Liu Y., Zhou Q.S., Tang Q.Z., Zou H.D. Comparison of the effects of propofol and midazolam on inflammation and oxidase stress in children with congenital heart disease undergoing cardiac surgery. Yonsei Med J 2011, 52:326-332.
31. Türe H., Mercan A., Koner O., Aykac B., Türe U. The effects of propofol infusion on hepatic and pancreatic function and acid-base status in children undergoing craniotomy and receiving phenytoin. Anesth Analg 2009, 109:366-371.